Advertisement

Virologica Sinica

, Volume 23, Issue 3, pp 226–231 | Cite as

Expression of human papillomavirus in mammary carcinoma and its possible mechanism in carcinogenesis

  • Chun-ling Fan
  • Jing-hua Zhou
  • Cheng-yi Hu
Article
  • 41 Downloads

Abstract

To explore the role of Human papillomavirus (HPV) in mammary carcinogenesis, the expression of the HPV-16, iNOS, P53 and hTERT proteins in breast carcinomas and their relationships were investigated. 52 samples of breast cancer and 16 samples of benign breast tumors were assayed using the immunohistochemical SP method for detection of protein expression levels. The expression of HPV-16, iNOS, P53 and hTERT proteins in a mammary carcinoma was 44.2%, 57.7%, 63.5% and 59.6% respectively, which was significantly greater than the corresponding levels in the benign group. The expression of iNOS, P53 and hTERT was correlated with the presence of an HPV-16 infection in a mammary carcinoma (P<0.05). The connection between these events might also involve the iNOS, mutated type P53 and the hTERT protein.

Key words

Mammary carcinoma Human papillomavirus (HPV) Inducible nitric oxide synthase P53 protein Human telomerase reverse transciptase 

CLC number

R373 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ambs S, Hussain S P, Harris C C. 1997. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J, 11: 443–448.PubMedGoogle Scholar
  2. 2.
    Ambs S, Merriam W G, Bennett W P, et al. 1998. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res, 58: 334–341.PubMedGoogle Scholar
  3. 3.
    Brennan P A, Controy B, Spedding A V, et al. 2000. Expression of inducible nitric oxide synthase and P53 in oral epithelial dyplasia. Oral Surg Oral Med Oral Radiol Endon, 90(5): 624–629.CrossRefGoogle Scholar
  4. 4.
    Ellie E, Loiseau H, Lafond F, et al. 1995. Differential expression of inducible nitric oxide synthase mRNA in human brain tumours. Neuroreport, 7: 294–296.PubMedGoogle Scholar
  5. 5.
    Erden E, Bulut A S, Sak S D, et al. 2005. Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium:an immunohisto chemical study of 151 cases. Virchow Arch, 447(1): 24–30.CrossRefGoogle Scholar
  6. 6.
    Felley-Bosco E. 1998. Role of nitric oxide in genotoxicity: implication for carcinogenesis. Cancer Metastasis Rev, 17: 25–37.PubMedCrossRefGoogle Scholar
  7. 7.
    Gallo O, Masini E, Morbidelli L, et al. 1998. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst, 90: 587–596.PubMedCrossRefGoogle Scholar
  8. 8.
    Geller D A, Billiar T R. 1998.Molecular biology of nitric oxide synthases. Cancer Metastasis Rev, 17: 7–23.PubMedCrossRefGoogle Scholar
  9. 9.
    James F, Crish, Frederic Bone, et al. 2000. Suprabasal expression of the human papillomavirus type 16 oncoproteins in mouse epidermis alters expression of cell cycle regulatory proteins. Carcinogenesis, 21(5): 1031–1037.CrossRefGoogle Scholar
  10. 10.
    Lala P K, Orucevic A. 1998. Role of nitric oxide in tumor progression: Lessons from experimental tumors. Cancer Metastasis Rev, 17: 91–106PubMedCrossRefGoogle Scholar
  11. 11.
    Liu X, H Yuan, B Fu, et al. 2005. The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein. J Biol Chem, 280: 10807–10816.PubMedCrossRefGoogle Scholar
  12. 12.
    Liu L. 2006. Expression of P53 and iNOS in tumor of ovary and their dependability. J Medical Res, 35(7): 71–73. (in Chinese)Google Scholar
  13. 13.
    Meng W, Hou G, JIA Y S, et al. 2004.Ralationship between iducible nitric oxide synthase and clinicopathological parameters in breast cancer and its siginificance. J Treat Prev, 11(8): 808–810. (in Chinese)Google Scholar
  14. 14.
    Nathan C, Xie Q. 1994. Regulation of biosynthesis of nitric oxide. J Biol Chem, 269: 13725–13728.PubMedGoogle Scholar
  15. 15.
    Reveneau S, Amouldb L, Jolimoy G, et al. 1999. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab Invest, 79(10): 1215–1225.PubMedGoogle Scholar
  16. 16.
    Thomsen L L, Miles D W, Happerfield L, et al. 1995. Nitric oxide synthase activity in human breast cancer. Br J Cancer, 72:41–44.PubMedGoogle Scholar

Copyright information

© Wuhan Institute of Virology, CAS and Springer-Verlag GmbH 2008

Authors and Affiliations

  1. 1.Heilongjiang August-first Land-Reclamation UniversityDaqingChina
  2. 2.Heilongjiang Chinese Medical UniversityHarbinChina
  3. 3.The 4th Hospital of Harbin Medical University HarbinHarbinChina

Personalised recommendations